Abstract
The aim of this study was to screen asthmatic children for bone density-related sonographic parameters on the calcaneal bone. Findings were correlated to therapy with inhaled corticosteroids (ICS) as well as with asthma severity (AS), concomitance and severity of atopic dermatitis (AD), and rhinitis (AR). We enrolled 173 children with AS1-3 consecutively; 44% (AS1) had not received any ICS medication; 56% (AS2 and −3) received ICS therapy for ≥6 months (medium daily dose, 286 μg fluticasone-proprionate-equivalent/maximum 500 μg); and in addition 38% (n = 65) presented with AD and 66% (n = 115) with AR. Broadband ultrasound attenuation (BUA) and speed of sound (SOS) results were compared to regional normative values of 3299 children obtained with the identical system. ICS-treated children showed a tendency toward reduced age-, weight-, and height-adjusted standard deviation scores (SDS) for SOS compared to children without ICS treatment, which tendency did not reach statistical significance and was not as consistent for BUA (mean of ICS-treated children compared to our controls: SOS-SDS, −0.29/−0.31/−0.30; BUA-SDS, −0.23/−0.17/−0.05). For ICS-treated children, the proportion of patients with BUA and SOS values below −1 SDS was statistically significant higher for age-adjusted BUA and SOS than for children without ICS medication (BUA 15.00% vs. 5.41%; SOS 32.98% vs. 17.56%). However, we cannot differentiate possible negative effects of ICS from influences of the underlying inflammatory disease because higher asthma severity was associated with greater use of ICS medication. Additionally, the higher physical activity of children with less severe asthma can have influenced quantitative ultrasound (QUS) parameters positively, compared to patients with a higher degree of exercise-induced symptoms. For differentiation of possible negative effect of ICS on ultrasonic bone quality and for evaluation of the potentials of the method, further longitudinal QUS assessment of asthmatics receiving a new ICS treatment is needed.
Similar content being viewed by others
References
Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, Wahn U; Multicenter Allergy Study Group (2004) Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age of 7 years and the association with asthma. J Allergy Clin Immunol 113:925–931
Chinn S, Jarvis D, Burney P, Luczynska C, Ackermann-Liebrich U, Antó JM, Cerveri I, De Marco R, Gislason T, Heinrich J, Janson C, Künzli N, Leynaert B, Neukirch F, Schouten J, Sunyer J, Svanes C, Vermeire P, Wjst M (2004) Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax 59:646–651
Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, Standring P, Steriu A, Goulding R (2004) Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12–14 year olds in the British Isles, 1995–2002: questionnaire survey. BMJ 328: 1052–1053
Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265–268
Ledford D, Apter A, Brenner AM, Rubin K, Prestwood K, Frieri M, Lukert B (1998) Osteoporosis in the corticosteroid-treated patient with asthma. J Allergy Clin Immunol 102:353–362
Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2005) Use of oral corticosteroids and risk of features. J Bone Miner Res 20:1487–1494; discussion 1486
Barnes PJ, Pedersen S (1993) Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 148:1–26
Hatoum HT, Schumock GT, Kendzierski DL (1994) Meta-analysis of controlled trials of drug therapy in mild chronic asthma: the role of inhaled corticosteroids. Ann Pharmacother 28:1285–1289
O’Connell EJ (2005) Optimizing inhaled corticosteroid therapy in children with chronic asthma. Pediatr Pulmonol 39:74–83
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143–178
Global Initiative for Asthma (1995) Global strategy for asthma management and prevention. Publication no. 95-3659. Heart, Lung and Blood Institute, Washington, DC
Hanania NA, Chapman KR, Sturtridge WC, Salai JP, Kesten S (1995) Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571–579
Woodcock A (1998) Effects of inhaled corticosteroids on bone density and metabolism. J Allergy Clin Immunol 101:456–459
Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N (2004) Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma. Pediatr Pulmonol 37:116–121
Medici TC, Grebski E, Häcki M, Rüegsegger P, Maden C, Efthimiou J (2000) Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects. Thorax 55:375–382
Agertoft L, Pederen S (1998) Bone mineral density in children with asthma receiving long term treatment with inhaled budesonide. Am J Respir Crit Care Med 157:178–183
Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA (1999) A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J 13:1267–1275
Packe GE, Robb O, Robins SP, Reid DM, Douglas JG (1996) Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J R Coll Phys Lond 30:128–132
Ebeling PR, Erbas B, Hopper JL, Wark JD, Rubinfeld AR (1998) Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 13: 1283–1289
Hanania NA, Chapman KR, Kesten S (1995) Adverse effects of inhaled corticosteroids. Am J Med 98:196–208
Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB (2000) Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 29:188–193
Hans D, Hartl F, Krieg MA (2003) Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland. Osteoporos Int 14:251–258
Malich A, Mainz J, John S, Vogt S, Beyermann H, Mentzel HJ, Wünsche K, Zintl F, Kaiser WA (2003) Early results of ultrasound based calculation of broadband ultrasound attenuation and speed of sound in children and adolescents suffering from asthma. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175: 366–373
van Lenthe GH, van den Bergh JP, Hermus AR, Huiskes R (2001) The prospects of estimating trabecular bone tissue properties from the combination of ultrasound, dual energy X-ray absorptiometry, microcomputed tomography, and microfinite element analysis. J Bone Miner Res 16:550–555
Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 157:629–634
Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348: 511–514
Yung PS, Lai YM, Tung PY, Tsui HT, Wong CK, Hung VW, Qin L (2005) Effects of weight bearing and non-weight bearing exercises on bone properties using calcaneal quantitative ultrasound. Br J Sports Med 39(8):547–551
Mentzel HJ, Wünsche K, Malich A, Böttcher J, Vogt S, Kaiser WA (2005) The effects of sports activities in children and adolescents on the calcaneus: an investigation with quantitative ultrasound. Rofo 177(4):524–529
Schalamon J, Singer G, Schwantzer G, Nietosvaara Y (2004) Quantitative ultrasound assessment in children with fractures. J Bone Miner Res 19(8):1276–1279
Drozdzowska B (2005) Skeletal status assessed by quantitative ultrasound at the calcaneus in females with bronchial asthma on prolonged corticosteroid therapy. Maturitas 51(4):386–392
Wünsche K, Wünsche B, Fähnrich H, Mentzel HJ, Vogt S, Abendroth K, Kaiser WA (2000) Ultrasound bone densitometry of the os calcis in children and adolescents. Calcif Tissue Int 67:349–355
American Thoracic Society (1962) Definition and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 85:762–768
Colice GL, Burgt JV, Song J, Stampone P, Thompson PJ (1999) Categorizing asthma severity Am J Respir Crit Care Med 160: 1962–1967
Wettengel R, Berdel D, Hofmann D, Krause J, Kroegel C, Kroidl RF, Leupold W, Lindemann H, Magnussen H, Meister R, Morr H, Nolte D, Rabe K, Reinhardt D, Sauer R, Schultze-Werninghaus G, Ukena D, Worth H (1998) Asthmatherapie bei Kindern und Erwachsenen. Med Klin 93:639–650
Consensus Report of the European Task Force on Atopic Dermatitis (1993) Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186:23–31
Frauman AG (1996) An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev 15:203–206
Martinati LC, Bertoldo F, Gasperi E, Fortunati P, Lo Cascio V, Boner AL (1998) Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium. Allergy 53:705–708
Baraldi E, Bollini MC, De Marchi A, Zacchello F (1994) Effect of beclomethasone dipropionate on bone mineral content assessed by x-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 7:710–714
Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355(9213):1399–1403
Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L (2004) Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trondelag Health Study (the HUNT Study). Pharmacoepidemiol Drug Saf 13(8): 569–579
Lipworth BJ (1999) Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159:941–955
Allen DB (2004) Systemic effects of inhaled corticosteroids in children. Curr Opin Pediatr 16:440–444
Leone FT, Fish JE, Szefler SJ, West SL (2003) Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124:2329–2340
Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ (2004) Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol 92:201–207
Mehta SS, Oz OK, Antich PP (1998) Bone elasticity and ultrasound velocity are affected by subtle changes in the organic matrix. J Bone Miner Res 13:114–121
Specker BL, Schoenau E (2005) Quantitative bone analysis in children: current methods and recommendations. J Pediatr 146:726–731
The WHO Study Group (1994) Assessment of fracture risk and its application to screening for menopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva
Frost ML, Blake GM, Fogelman I (2001) Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res 16:406–416
Imamoto K, Saito N, Yamamura Y, Yamamura I (1996) Bone mineral density of the calcanei dissected from 30 cadavers: correlation of the values by the DXA, QCT and USD methods. Nippon Ronen Igakkai Zasshi 33:597–602
Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J (1991) Vertebral fracture in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46: 803–806
Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787
Cepollaro C, Gonnelli S, Rottoli P, Montagnani A, Caffarelli C, Bruni D, Nikiforakis N, Fossi A, Rossi S, Nuti R (2005) Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int 16(7):743–748
Tanaka H (2007) Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment (in Japanese). Clin Calcium 17(7):1114–1119
Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y The Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23(2): 105–109
Teitelbaum JE, Rodriguez RJ, Ashmeade TL, Yaniv I, Osuntokun BO, Hudome S, Fanaroff A (2006) Quantitative ultrasound in the evaluation of bone status in premature and full-term infants. J Clin Densitom 9(3):358–362
Author information
Authors and Affiliations
Corresponding author
Additional information
First results of the presented study have been published previously in a German radiological paper: Malich A, Mainz J, John S, Vogt S, Beyermann H, Mentzel HJ, Wunsche K, Zintl F, Kaiser WA. Erste Ergebnisse der ultraschallbasierten Bestimmung der Knochendichte bei Kindern mit Asthma bronchiale. [Early results of ultrasound-based calculation of broadband ultrasound attenuation and speed of sound in children and adolescents suffering from asthma]. Rofo 2003;175(3): 366–373
About this article
Cite this article
Mainz, J.G., Sauner, D., Malich, A. et al. Cross-sectional study on bone density-related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severity. J Bone Miner Metab 26, 485–492 (2008). https://doi.org/10.1007/s00774-008-0860-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-008-0860-6